NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT03746431 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 InjectionFusion Pharmaceuticals Inc.Phase 1 Terminated78 enrolled